BioSpace News Archive

Technavio has announced their latest drug pipeline analysis report on sickle cell anemia. The report includes a comprehensive research on the pipeline molecules under investigation by the pharmaceutical companies within the defined data collection period for the treatment of sickle cell anemia.

Tele-News Conference: New research and polling data will be released during ACEP’s annual meeting (ACEP18)

Today, George W. Bush, 43rd President of the United States, spoke at a summit celebrating the 15th anniversary of Medicare Part D. The event was hosted by MAPRx - a coalition convened by the Lupus Foundation of America (LFA) consisting of more than 55 patient, family caregiver and health professional organizations committed to strengthening and protecting Medicare Part D.

First-ever human use of eRapa in clinical trial at UT Health San Antonio MD Anderson Cancer Center will test safety, effective dose and tolerability in early-stage prostate cancer patients, and explore how the drug could boost the immune system for a multitude of age-related diseases

enter For Discovery, the largest provider of eating disorders treatment in Southern California and a leader nationwide with more than 60 residential and outpatient facilities, has opened its latest center in Glendale, Calif., it was announced today.

Signature Performance, Inc. (SPI) announces that it was awarded a GSA/FAS schedule contract for Information Technology (IT) Schedule 70 for its technology equipment, software and services under IT Professional Services SIN 132-51 and Health IT Services SIN132-56.

CRCC and Digitec Interactive won a coveted Brandon Hall Group silver award for excellence in the Best Use of Section 508 Requirements for Training Programs category. CRCC e-UNIVERSITY provides a flexible learning portal for rehabilitation counselors to maintain their CRC certification.

The Tampa Bay Rays have completed construction of a Recovery Room Powered by NormaTec. Located under the dome at Tropicana Field

On September 10th, 2018, Life Sciences Ontario hosted a roundtable discussion with the Minister of Innovation, Science and Economic Development, Navdeep Bains, and Mississauga Mayor Bonnie Crombie, along with key industry partners from the life sciences sector.

Phase 3 study successfully meets primary and secondary endpoints, demonstrating significant relief of average and worst pain in patients on CAM2038 compared to placebo (p<0.001)